cysteine has been researched along with Craniofacial Dysarthrosis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, M; Ke, R; Lei, J; Mu, X; Tianyi, C; Yang, X | 1 |
| Ang, BU; Kirschner, RE; Nah, HD; Spivak, RM | 1 |
| Anderson, PJ; Cox, TC; David, DJ; Netherway, DJ; Roscioli, T | 1 |
| Darvann, T; Morriss-Kay, G; Ornitz, DM; Perlyn, CA; Tenenbaum, M | 1 |
| Müller, U; Mulliken, JB; Steinberger, D | 1 |
| Anderson, C; Can, B; Say, B; Schaefer, F | 1 |
| Donoghue, DJ; Galvin, BD; Hart, KC; Meyer, AN; Robertson, SC; Webster, MK | 1 |
| Büsse, M; Collmann, H; Halliger-Keller, B; Kress, W; Mueller, CR | 1 |
8 other study(ies) available for cysteine and Craniofacial Dysarthrosis
| Article | Year |
|---|---|
The C342R mutation in FGFR2 causes Crouzon syndrome with elbow deformity.
Topics: Amino Acid Substitution; Arginine; Asian People; Child; Child, Preschool; China; Craniofacial Dysostosis; Cysteine; Elbow Joint; Female; Genetic Carrier Screening; Humans; Joint Dislocations; Male; Mutation; Olecranon Process; Phenotype; Receptor, Fibroblast Growth Factor, Type 2 | 2015 |
Dura in the pathogenesis of syndromic craniosynostosis: fibroblast growth factor receptor 2 mutations in dural cells promote osteogenic proliferation and differentiation of osteoblasts.
Topics: Acrocephalosyndactylia; Adenoviridae; Alkaline Phosphatase; Animals; Arginine; Biomarkers; Cell Differentiation; Cell Proliferation; Cells, Cultured; Coculture Techniques; Coloring Agents; Core Binding Factor Alpha 1 Subunit; Craniofacial Dysostosis; Craniosynostoses; Cysteine; Dura Mater; Genetic Vectors; Mice; Osteoblasts; Osteogenesis; Osteopontin; Phenylalanine; Point Mutation; Receptor, Fibroblast Growth Factor, Type 2; Syndrome; Tetrazolium Salts; Thiazoles | 2010 |
Do Craniosynostosis syndrome phenotypes with both FGFR2 and TWIST mutations have a worse clinical outcome?
Topics: Acrocephalosyndactylia; Adenine; Adolescent; Arginine; Child, Preschool; Craniofacial Dysostosis; Craniosynostoses; Cysteine; Cytosine; DNA Transposable Elements; Female; Follow-Up Studies; Guanine; Humans; Male; Mutation; Receptor, Fibroblast Growth Factor, Type 2; Sequence Deletion; Serine; Syndrome; Thymine; Treatment Outcome; Tryptophan; Twist-Related Protein 1 | 2006 |
A model for the pharmacological treatment of crouzon syndrome.
Topics: Animals; Cranial Sutures; Craniofacial Dysostosis; Cysteine; Disease Models, Animal; Mice; Mice, Mutant Strains; Mutation; Pyrimidines; Receptor, Fibroblast Growth Factor, Type 2; Receptors, Fibroblast Growth Factor; Tissue Culture Techniques; Tomography, X-Ray Computed; Tyrosine | 2006 |
Predisposition for cysteine substitutions in the immunoglobulin-like chain of FGFR2 in Crouzon syndrome.
Topics: Base Sequence; Craniofacial Dysostosis; Cysteine; Humans; Immunoglobulin Heavy Chains; Molecular Sequence Data; Mutation; Pedigree; Polymorphism, Single-Stranded Conformational; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 2; Receptors, Fibroblast Growth Factor | 1995 |
Novel mutation in the FGFR2 gene at the same codon as the Crouzon syndrome mutations in a severe Pfeiffer syndrome type 2 case.
Topics: Acrocephalosyndactylia; Amino Acid Sequence; Codon; Craniofacial Dysostosis; Cysteine; Exons; Female; Humans; Infant, Newborn; Molecular Sequence Data; Mutation; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 2; Receptors, Fibroblast Growth Factor; Tryptophan | 1998 |
Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain.
Topics: Amino Acid Sequence; Animals; COS Cells; Craniofacial Dysostosis; Cysteine; Dimerization; Disulfides; Humans; Immunoglobulins; Models, Molecular; Molecular Sequence Data; Musculoskeletal Abnormalities; Point Mutation; Protein Structure, Secondary; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 2; Receptors, Fibroblast Growth Factor; Recombinant Fusion Proteins; Recombinant Proteins; Transfection | 1998 |
Clustering of FGFR2 gene mutations inpatients with Pfeiffer and Crouzon syndromes (FGFR2-associated craniosynostoses).
Topics: Acrocephalosyndactylia; Amino Acid Sequence; Cohort Studies; Craniofacial Dysostosis; Cysteine; DNA Mutational Analysis; Female; Genetic Testing; Humans; Male; Molecular Sequence Data; Mutagenesis; Mutation; Nuclear Proteins; Pedigree; Phenotype; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 2; Receptors, Fibroblast Growth Factor; Syndrome; Transcription Factors; Twist-Related Protein 1 | 2000 |